100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Human CD69 Antibody [FN50] (AGEL1689)

SKU AGEL1689
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FC
Reactivity Human
Host Species Mouse
Isotype IgG2a,k
Clone FN50
Conjugation APC
€63 - €240

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Human CD69 Antibody [FN50]

The Human CD69 Monoclonal Antibody (APC conjugated) (FN50) is a vital tool for researchers investigating CD69, a cell surface molecule known for its role in immune responses and lymphocyte activation. This monoclonal antibody, conjugated with APC for flow cytometry applications, is specifically designed for use in studying human samples.CD69, a C-type lectin receptor, is involved in the early activation of lymphocytes and is considered a marker for lymphocyte activation. Its expression is induced rapidly upon lymphocyte activation, making it a valuable target for studies focusing on immune responses, infectious diseases, and inflammatory conditions.

This antibody, generated through the FN50 clone, provides high specificity and sensitivity, enabling accurate detection and analysis of CD69 expression in various cell types.Researchers in immunology, infectious diseases, and cancer biology will find this APC-conjugated CD69 monoclonal antibody essential for their studies. By utilizing this antibody, researchers can delve deeper into the mechanisms underlying immune responses and lymphocyte activation, ultimately contributing to advancements in therapeutic strategies targeting immune-related disorders and diseases.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose